CD274 and neoplasm: Upon binding to these ligands, PD‐1 acts to inhibit T cells.14 PD‐L1 is expressed both by cancer cells and tumor‐infiltrating lymphocytes and upregulation of PD‐L1 on tumor cells is an adaptive mechanism to facilitate immune evasion.